The impact of voxelotor treatment on leg ulcers in patients with sickle cell disease

Am J Hematol. 2021 Apr 1;96(4):E126-E128. doi: 10.1002/ajh.26101. Epub 2021 Feb 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Pain / etiology
  • Adolescent
  • Adult
  • Anemia, Sickle Cell / blood
  • Anemia, Sickle Cell / complications*
  • Benzaldehydes / therapeutic use*
  • Child
  • Clinical Trials, Phase III as Topic / statistics & numerical data
  • Double-Blind Method
  • Female
  • Hemoglobin, Sickle / drug effects
  • Humans
  • Incidence
  • Leg Ulcer / drug therapy*
  • Leg Ulcer / etiology
  • Leg Ulcer / prevention & control
  • Male
  • Middle Aged
  • Pyrazines / therapeutic use*
  • Pyrazoles / therapeutic use*
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Treatment Outcome
  • Young Adult

Substances

  • Benzaldehydes
  • Hemoglobin, Sickle
  • Pyrazines
  • Pyrazoles
  • voxelotor

Associated data

  • ClinicalTrials.gov/NCT03036813